Earlier this week, Labcorp announced the nationwide availability of ColoSense, the first FDA-approved RNA-based at-home colorectal cancer screening test, now covered for eligible Medicare and Medicare ...

Labcorp currently trades at $265.08 per share and has shown little upside over the past six months, posting a middling return of 4.4%. Is now the time to buy Labcorp, or should you be careful about ...

Ashley St. Clair's best-known claim here is not just that Elon Musk fathered her child, but that the money he says he has sent is not the same as the financial pressure she says she is now under. In a ...

Shares of Labcorp Holdings Inc. LH slipped 1.34% to $271.99 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.38% to ...

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

Economy is one of the most important categories in CNBC’s annual America’s Top States for Business rankings. Several states ...

If you receive JavaScript required to sign in error message when using Skype, OneDrive, Teams or any other program, you need to turn on or enable JavaScript in your ...

Ultrahuman M2 Live brings no-prescription glucose tracking to the US using Abbott’s Lingo CGM, with plans starting at $99 per month.

Doug Wintemute is a staff writer for Forbes Advisor. After completing his master’s in English at York University, he began his writing career in the higher education space. Over the past decade, Doug ...

Armed conflict in eastern Ukraine erupted in early 2014 following Russia’s annexation of Crimea. The previous year, protests in Ukraine’s capital, Kyiv, against Ukrainian President Viktor Yanukovych’s ...

The NASCAR Cup Series’ In-Season Challenge returns for its second season in 2026, bringing a five-race, bracket-style tournament to TNT Sports’ portion of the summer schedule. Thirty-two drivers ...